INVA EBITDA | INNOVIVA, INC.

INNOVIVA, INC. (INVA) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $50.85M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $38.15M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $34.58M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $48.75M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2022-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$50.85M	(m)	$119.59M	(m)	$429.00K*	$51.97M*	(m)	$5.19M	$34.57M	-$24.60M
2026-03-31	Reported	(m)	$38.15M	(m)	$97.99M	(m)	$492.00K	$35.28M	(m)	$5.24M	$32.44M	$47.97M
2025-09-30	Reported	(m)	$34.58M	(m)	$107.80M	(m)	$1.12M*	$49.73M*	(m)	$13.67M	$27.29M	$7.91M
2025-06-30	Reported	(m)	$48.75M	(m)	$100.28M	(m)	$0.00*	$44.07M*	(m)	$7.98M	$26.41M	$8.91M
2025-03-31	Reported	(m)	$41.43M	(m)	$88.63M	(m)	$0.00	$48.62M	(m)	$4.40M	$27.49M	$8.00M
2024-09-30	Reported	(m)	$43.24M	(m)	$89.51M	(m)	$270.00K*	$48.69M*	(m)	$3.55M	$26.22M	$5.64M
2024-06-30	Reported	(m)	$54.69M	(m)	$99.90M	(m)	$0.00*	$43.72M*	(m)	$2.56M	$27.74M	-$4.59M
2024-03-31	Reported	(m)	$25.80M	(m)	$77.50M	(m)	$0.00	$37.05M	(m)	$3.88M	$30.41M	$8.59M
2022-06-30	Reported	$86.14M*	$82.55M	$3.59M*	$108.22M	79.60%*	$13.00K*	$79.03M*	(m)	$13.88M	$11.78M	-$876.00K
2022-03-31	Reported	$81.23M	(m)	(m)	(m)	90.20%	$9.00K	$98.10M	(m)	$5.84M	$6.49M	$6.86M
2021-12-31	Reported	$107.98M	(m)	(m)	(m)	100.28%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$98.01M*	$94.55M	$3.46M*	$97.86M	100.15%*	$0.00*	$96.71M*	(m)	$449.00K	$2.86M	$20.53M
2021-06-30	Reported	$100.00M*	$96.54M	$3.46M*	$100.81M	99.20%*	$0.00*	$84.61M*	(m)	$38.00K	(m)	$25.33M
2021-03-31	Reported	$82.94M	(m)	(m)	(m)	96.99%	$0.00	$84.11M	(m)	$49.00K	(m)	$19.74M
2020-12-31	Reported	$88.25M	(m)	(m)	(m)	97.53%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$87.89M*	$84.43M	$3.46M*	$88.69M	99.09%*	$0.00*	$74.56M*	(m)	$1.01M	(m)	$8.87M
2020-06-30	Reported	$79.25M*	$75.79M	$3.46M*	$78.95M	100.38%*	$0.00*	$79.79M*	(m)	$559.00K	(m)	$19.89M
2020-03-31	Reported	$79.58M	(m)	(m)	(m)	101.14%	$13.00K	$73.48M	(m)	$0.00	(m)	$15.93M
2019-12-31	Reported	$77.11M	(m)	(m)	(m)	101.50%	(m)	(m)	(m)	(m)	(m)	$12.40M
2019-09-30	Reported	$64.11M*	$60.79M	$3.32M*	$65.75M	97.50%*	$0.00*	$57.40M*	(m)	$0.00	(m)	$10.56M
2019-06-30	Reported	$63.30M*	$59.76M	$3.54M*	$64.11M	98.74%*	$0.00*	$56.50M*	(m)	$0.00	(m)	$10.43M
2019-03-31	Reported	$55.71M	(m)	(m)	(m)	100.95%	$0.00	$76.66M	(m)	(m)	(m)	$8.51M
2018-12-31	Reported	$80.69M	(m)	(m)	(m)	101.04%	(m)	(m)	(m)	(m)	(m)	-$196.07M
2018-09-30	Reported	$61.13M*	$57.66M	$3.47M*	$61.68M	99.11%*	(m)	$60.12M*	(m)	$0.00	(m)	$0.00
2018-06-30	Reported	$66.14M*	$62.67M	$3.47M*	$67.09M	98.59%*	(m)	$51.73M*	(m)	$0.00	(m)	$0.00
2018-03-31	Reported	$44.16M	(m)	(m)	(m)	84.31%	(m)	$49.91M	(m)	$0.00	(m)	$0.00
2017-12-31	Reported	$69.9M	(m)	(m)	(m)	100.55%	(m)	(m)	(m)	(m)	(m)	$4.00K
2017-09-30	Reported	$43.52M*	$40.02M	$3.50M*	$48.64M	89.46%*	$0.00*	$43.49M*	(m)	$311.00K	(m)	$0.00
2017-06-30	Reported	$51.33M*	$47.83M	$3.50M*	$58.56M	87.64%*	(m)	$22.64M*	(m)	$348.00K	(m)	$0.00
2017-03-31	Reported	$32.84M	(m)	(m)	(m)	81.10%	(m)	$27.76M	(m)	$354.00K	(m)	$0.00
2016-12-31	Reported	$41.16M	(m)	(m)	(m)	94.37%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$31.41M*	$27.92M	$3.49M*	(m)	(m)	$242.00K*	$20.19M*	(m)	$286.00K	(m)	(m)
2016-06-30	Reported	$29.36M*	$25.88M	$3.48M*	(m)	(m)	$8.00K*	$12.46M*	(m)	$370.00K	(m)	(m)
2016-03-31	Reported	$21.02M	(m)	(m)	(m)	86.93%	$0.00	$7.25M	(m)	$392.00K	(m)	(m)
2015-12-31	Reported	$20.78M	(m)	(m)	(m)	90.98%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$11.92M*	$8.43M	$3.48M*	(m)	(m)	$0.00*	$2.66M*	(m)	$547.00K	(m)	$0.00
2015-06-30	Reported	$8.59M*	$5.11M	$3.48M*	(m)	(m)	$0.00*	$2.17M*	(m)	$638.00K	(m)	$0.00
2015-03-31	Reported	$4.23M	(m)	(m)	(m)	61.31%	$6.00K	-$1.62M	(m)	$712.00K	(m)	(m)
2014-12-31	Reported	$3.59M	(m)	(m)	(m)	49.24%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$7.01M*	-$9.54M	$2.53M*	(m)	(m)	$0.00*	-$21.07M*	(m)	$1.91M	(m)	-$278.00K
2014-06-30	Reported	-$6.24M*	-$9.79M	$3.55M*	(m)	(m)	-$1.06M*	-$54.41M*	(m)	$2.13M	(m)	$278.00K
2014-03-31	Reported	-$12.09M	(m)	(m)	(m)	1549.36%	$1.62M	-$50.64M	(m)	$2.69M	$22.83M	(m)
2013-12-31	Reported	-$5.92M	(m)	(m)	(m)	-401.77%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$7.78M*	-$7.71M	-$77.00K*	(m)	(m)	$236.00K*	-$41.31M*	(m)	$2.10M	$12.28M	$0.00
2013-06-30	Reported	-$6.76M*	-$6.90M	$138.00K*	(m)	(m)	$691.00K*	(m)	(m)	$2.41M	(m)	$0.00
2013-03-31	Reported	-$31.49M	(m)	(m)	(m)	-2342.93%	$740.00K	(m)	(m)	$26.42M	$8.31M	(m)
2012-12-31	Reported	-$44.34M	(m)	(m)	(m)	35.66%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$31.46M*	-$33.35M	$1.89M*	(m)	(m)	$567.00K*	(m)	(m)	$27.03M	$7.75M	(m)
2012-06-30	Reported	-$34.05M*	-$35.71M	$1.66M*	(m)	(m)	$659.00K*	(m)	(m)	$29.55M	(m)	(m)
2012-03-31	Reported	$87.95M	(m)	(m)	(m)	69.20%	$1.10M	(m)	(m)	$33.20M	(m)	(m)
2011-12-31	Reported	-$33.45M	(m)	(m)	(m)	-623.85%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$27.15M*	-$29.20M	$2.05M*	(m)	(m)	-$40.00K*	(m)	(m)	$27.84M	(m)	(m)
2011-06-30	Reported	-$21.90M*	-$23.66M	$1.76M*	(m)	(m)	$1.38M*	(m)	(m)	$22.80M	(m)	(m)
2011-03-31	Reported	-$19.65M	(m)	(m)	(m)	-310.41%	$1.38M	(m)	(m)	$20.46M	(m)	(m)
2010-12-31	Reported	-$16.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$18.29M*	-$19.84M	$1.56M*	(m)	(m)	$153.00K*	(m)	(m)	$18.54M	(m)	(m)
2010-06-30	Reported	(m)	-$19.43M	(m)	(m)	(m)	(m)	(m)	(m)	$18.70M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$163.75M	(m)	$411.33M	(m)	$1.13M	$196.93M	(m)	$30.60M	$113.32M	$55.70M
2024-12-31	Reported	(m)	$166.87M	(m)	$358.71M	(m)	$270.00K	$188.69M	(m)	$13.65M	$115.69M	$14.00M
2023-12-31	Reported	(m)	$113.89M	(m)	$310.46M	(m)	$411.00K	$141.06M	(m)	$33.92M	$98.23M	$14.38M
2021-12-31	Reported	$388.94M	(m)	(m)	(m)	99.25%	$0.00	$363.81M	(m)	$576.00K	$16.19M	$76.44M
2020-12-31	Reported	$334.96M	(m)	(m)	(m)	99.46%	$13.00K	$313.11M	(m)	$1.79M	$13.88M	$60.43M
2020-09-30	Rolling	(m)	$309.98M*	(m)	$322.29M*	(m)	(m)	(m)	(m)	(m)	(m)	$57.09M*
2020-06-30	Rolling	(m)	$286.34M*	(m)	$299.35M*	(m)	(m)	(m)	(m)	(m)	(m)	$58.78M*
2020-03-31	Rolling	(m)	$270.31M*	(m)	$284.51M*	(m)	(m)	(m)	(m)	(m)	(m)	$49.33M*
2019-12-31	Reported	$260.23M	(m)	(m)	(m)	99.70%	$12.00K	$257.46M	(m)	$0.00	(m)	$41.90M
2019-12-31	Rolling	(m)	$246.36M*	(m)	$261.02M*	(m)	(m)	(m)	(m)	(m)	(m)	$41.90M*
2019-09-30	Rolling	(m)	$249.94M*	(m)	$264.90M*	(m)	(m)	(m)	(m)	(m)	(m)	-$166.57M*
2019-06-30	Rolling	(m)	$246.81M*	(m)	$260.83M*	(m)	(m)	(m)	(m)	(m)	(m)	-$177.13M*
2019-03-31	Rolling	(m)	$249.72M*	(m)	$263.81M*	(m)	(m)	(m)	(m)	(m)	(m)	-$187.56M*
2018-12-31	Reported	$252.12M	(m)	(m)	(m)	96.60%	$0.00	$223.53M	(m)	$0.00	(m)	-$196.07M
2018-12-31	Rolling	(m)	$238.25M*	(m)	$261.00M*	(m)	(m)	(m)	(m)	(m)	(m)	-$196.07M*
2018-09-30	Rolling	(m)	$227.44M*	(m)	$250.67M*	(m)	(m)	(m)	(m)	(m)	(m)	$4.00K*
2018-06-30	Rolling	(m)	$209.80M*	(m)	$237.63M*	(m)	(m)	(m)	(m)	(m)	(m)	$4.00K*
2018-03-31	Rolling	(m)	$194.96M*	(m)	$229.10M*	(m)	(m)	(m)	(m)	(m)	(m)	$4.00K*
2017-12-31	Reported	$197.59M	(m)	(m)	(m)	90.96%	$0.00	$141.75M	(m)	$1.35M	(m)	$4.00K
2017-12-31	Rolling	(m)	$183.60M*	(m)	$217.22M*	(m)	(m)	(m)	(m)	(m)	(m)	$4.00K*
2017-09-30	Rolling	(m)	$154.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	$142.75M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	$120.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	$122.94M	(m)	(m)	(m)	92.04%	$278.00K	$60.98M	(m)	$1.39M	(m)	$95.00K
2016-12-31	Rolling	(m)	$108.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	$88.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	$69.14M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	$48.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	$45.51M	(m)	(m)	(m)	84.36%	$7.00K	$10.13M	(m)	$2.62M	(m)	$0.00
2015-12-31	Rolling	(m)	$31.58M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$21.75M	(m)	(m)	(m)	-257.96%	$689.00K	-$130.72M	(m)	$7.50M	(m)	$0.00
2013-12-31	Reported	-$25.34M	(m)	(m)	(m)	-559.07%	$2.73M	-$129.60M	(m)	$9.04M	$48.44M	$0.00
2012-12-31	Reported	-$21.9M	(m)	(m)	(m)	-390.08%	$2.59M	-$127.51M	(m)	$8.15M	$30.86M	$0.00
2011-12-31	Reported	-$102.15M	(m)	(m)	(m)	-416.75%	$3.63M	(m)	(m)	$103.57M	$30.68M	$0.00
2010-12-31	Reported	-$71.99M	(m)	(m)	(m)	-297.18%	$861.00K	(m)	(m)	$75.07M	(m)	(m)
2009-12-31	Reported	-$75.82M	(m)	(m)	(m)	-311.07%	$744.00K	(m)	(m)	$77.52M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
OMEROS CORP (OMER)	United States	$1.456B	5.50
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82
Oric Pharmaceuticals, Inc. (ORIC)	United States	$1.367B	-8.00
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10